Evidence map›Paper›PMID 36611979›Full record

ArticleCells2023

Transcriptomic Analysis Reveals JAK2/MPL-Independent Effects of Calreticulin Mutations in a

Ana Guijarro-Hernández, Laura Eder-Azanza, Cristina Hurtado, David Navarro-Herrera, Begoña Ezcurra, Francisco Javier Novo, Juan Cabello, José Luis Vizmanos

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. The Role of Mutated Calreticulin in the Pathogenesis ofInternational journal of molecular sciences · 2024
    Article
  4. Cancers · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ana Guijarro-HernándezDepartment of Biochemistry and Genetics, School of Sciences, University of Navarra, 31008 Pamplona, Spain.ORCID 0000-0003-1061-7744
Laura Eder-AzanzaDepartment of Biochemistry and Genetics, School of Sciences, University of Navarra, 31008 Pamplona, Spain.
Cristina HurtadoDepartment of Biochemistry and Genetics, School of Sciences, University of Navarra, 31008 Pamplona, Spain.
David Navarro-HerreraDepartment of Biochemistry and Genetics, School of Sciences, University of Navarra, 31008 Pamplona, Spain.
Begoña EzcurraCenter for Biomedical Research of La Rioja (CIBIR), 26006 Logroño, Spain.
Francisco Javier NovoDepartment of Biochemistry and Genetics, School of Sciences, University of Navarra, 31008 Pamplona, Spain.ORCID 0000-0003-4961-3097
Juan CabelloCenter for Biomedical Research of La Rioja (CIBIR), 26006 Logroño, Spain.
José Luis VizmanosDepartment of Biochemistry and Genetics, School of Sciences, University of Navarra, 31008 Pamplona, Spain.ORCID 0000-0001-7416-3679
Universidad de Navarra · ESCenter for Biomedical Research of La Rioja · ESNavarre Institute of Health Research · ES

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
NIH HHS P40 OD010440
6 · The paper itself

Abstract

There is growing evidence that

Indexed as

Caenorhabditis elegansMyeloproliferative DisordersAnimalsCalreticulinHedgehog ProteinsJanus Kinase 2MammalsMutationTranscriptomeCalreticulinHedgehog ProteinsJanus Kinase 2Caenorhabditis elegansCALRJAK2MPLmyeloproliferative neoplasms

Identifiers

PMID36611979
PMCPMC9818371
OpenAlexW4313433250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.